EUVIMEDEUVIMED entdecken
Crossref

Antitumor Activity of Symmetrical Selenoesters in Doxorubicin Resistant Breast Cancer

Balint Racz, Erzsebet Kristof, Annamaria Kincses, Enrique Dominguez-Alvarez, Gabriella Spengler

Anticancer Research · 2023-11 · 43 (11) · 4865-4872

DOI: 10.21873/anticanres.16683 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 01.11.2023. Verfasst von Balint Racz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Albert Szent-Györgyi Health Center and Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Previously, selenocompounds (Se-compounds) and in particular selenoesters have shown promising anticancer activities. Since molecular symmetry can enhance the anticancer activity, nine symmetrical selenoesters (Se-esters) have been designed as novel, potentially active anticancer agents against doxorubicin resistant breast cancer cells. MATERIALS AND METHODS: To assess the biological effects of the symmetrical Se-esters, the antiproliferative activity was determined on sensitive MCF-7 and doxorubicin resistant KCR breast cancer cell lines. The interaction of the derivatives with doxorubicin was evaluated by checkerboard combination assay on KCR cells. Furthermore, apoptosis induction and ATPase activity in the presence of Se-esters were also determined on KCR cells. RESULTS: The symmetrical derivatives showed a noteworthy antiproliferative activity, with two of them showing IC50 values in submicromolar concentration on MCF-7 cells. In addition, some derivatives showed selectivity towards the resistant KCR cells. The combination of most of them with doxorubicin resulted in synergistic interaction, and all Se-esters could induce early and late apoptosis in KCR cells. Finally, the compounds affected the ATPase activity of ABCB1 (P-gp). CONCLUSION: The symmetrical Se-esters showed potent anticancer activity, according to in vitro tests. Further research needs to be performed to obtain similar derivatives with a better activity and selectivity, and to ascertain the potential application of these Se-containing compounds using in vivo systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleDoxorubicinApoptosisBiological AssayEstersAdenosine Triphosphatases

Stichwörter der Autor:innen

Multidrug resistanceP-glycoprotein (ABCB1, P-gp)apoptosisbreast cancerdoxorubicinselenoester

Substanzen

DoxorubicinEstersAdenosine Triphosphatases

Autor:innen und Institutionen

  • Department of Medical Microbiology, Albert Szent-Györgyi Health Center and Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Institute of Pharmacognosy, Faculty of Pharmacy, University of Szeged, Szeged, Hungary.
  • Instituto de Química Orgánica General (IQOG), CSIC, Madrid, Spain e.dominguez-alvarez@iqog.csic.es.
  • Department of Medical Microbiology, Albert Szent-Györgyi Health Center and Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary; spengler.gabriella@med.u-szeged.hu.

Zitieren

APA

Racz, B., Kristof, E., Kincses, A., Dominguez-Alvarez, E., & Spengler, G. (2023). Antitumor Activity of Symmetrical Selenoesters in Doxorubicin Resistant Breast Cancer. Anticancer Research, 43(11), 4865-4872. https://doi.org/10.21873/anticanres.16683

Vancouver

Racz B, Kristof E, Kincses A, Dominguez-Alvarez E, Spengler G. Antitumor Activity of Symmetrical Selenoesters in Doxorubicin Resistant Breast Cancer. Anticancer Research. 2023;43(11):4865-4872. doi:10.21873/anticanres.16683

BibTeX
@article{Racz2023,
  author = {Racz, Balint and Kristof, Erzsebet and Kincses, Annamaria and Dominguez-Alvarez, Enrique and Spengler, Gabriella},
  title = {Antitumor Activity of Symmetrical Selenoesters in Doxorubicin Resistant Breast Cancer},
  journal = {Anticancer Research},
  year = {2023},
  volume = {43},
  number = {11},
  pages = {4865--4872},
  doi = {10.21873/anticanres.16683}
}
Kostenlos starten →